Genetics testing company 23andMe said on Monday that it is cutting its headcount by 40%, or more than 200 employees.The job cuts come as 23andMe seeks to undergo a restructuring that the company said will "streamline operations and reduce costs.

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at the company. The genetic testing company is also discontinuing its therapeutics business and winding down its clinical trials;